p38 Mitogen-activated protein kinase (p38 MAPK) (p38 MAPK)

The p38 mitogen-activated protein kinase (MAPK) pathway is a central signaling cascade that mediates cellular responses to environmental stressors, such as osmotic shock and UV radiation, as well as pro-inflammatory cytokines like TNF-alpha and IL-1 beta [1, 6]. The pathway is characterized by a three-tiered kinase hierarchy where upstream MAP3Ks activate MAP2Ks (specifically MKK3, MKK6, and sometimes MKK4), which then dually phosphorylate the p38 MAPK isoforms: p38-alpha (MAPK14), p38-beta (MAPK11), p38-gamma (MAPK12), and p38-delta (MAPK13) [2, 22]. p38-alpha is the most prominent isoform in most tissues and plays a pivotal role in the post-transcriptional regulation of pro-inflammatory gene expression by stabilizing mRNAs containing AU-rich elements [8, 22]. Dysregulation of p38 MAPK signaling is a hallmark of various pathological states, including rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and neurodegenerative diseases like Alzheimer's [12, 16]. While numerous small-molecule inhibitors have been developed to target p38-alpha/beta, many have faced challenges in clinical trials due to dose-limiting toxicities, such as hepatotoxicity and skin rashes, or a lack of sustained clinical benefit in chronic inflammatory conditions [14, 20]. Current therapeutic efforts focus on selective isoform inhibition and allosteric modulation to improve the safety profile and efficacy of p38-targeted therapies [5, 7].

Other names

SAPK2RKCSBPCytokine suppressive drug-binding proteinStress-activated protein kinase 2Mitogen-activated protein kinase 14 (MAPK14)Mitogen-activated protein kinase 11 (MAPK11)Mitogen-activated protein kinase 12 (MAPK12)Mitogen-activated protein kinase 13 (MAPK13)

Small-molecule inhibitors typically target the p38 MAPK isoforms through ATP-competitive binding or allosteric inhibition (Type II inhibitors). These drugs prevent the phosphorylation of downstream substrates, such as MAPKAPK2 (MK2) and various transcription factors, thereby suppressing the production of pro-inflammatory cytokines like TNF-alpha and IL-1 beta.